|
|
Volumn 81, Issue 6, 1996, Pages 2027-2029
|
|
Editorial: Long term tamoxifen therapy: Can an antagonist become an agonist?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
TAMOXIFEN;
ANTIESTROGEN;
ESTROGEN;
BINDING SITE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER CELL;
CANCER RECURRENCE;
CANCER SURVIVAL;
EDITORIAL;
HUMAN;
PRIORITY JOURNAL;
RECEPTOR BINDING;
TATA BOX;
BREAST TUMOR;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG POTENTIATION;
FEMALE;
RANDOMIZED CONTROLLED TRIAL;
TIME;
BREAST NEOPLASMS;
ESTROGEN ANTAGONISTS;
ESTROGENS;
FEMALE;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
TAMOXIFEN;
TIME FACTORS;
|
|
EID: 0030161996
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jc.81.6.2027 Document Type: Editorial |
|
Times cited : (34)
|
|
References (0)
|
